Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2160353 | Radiotherapy and Oncology | 2008 | 6 Pages |
Abstract
S-1 is a novel, oral fluoropyrimidine and a known radiosensitizer. We conducted a phase I trial to establish a schedule of S-1/irinotecan with standard pelvic radiotherapy as a preoperative treatment of locally advanced rectal cancer. Our findings suggest that this new combination is feasible and well tolerable.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hye Jin Choi, Nam-Kyu Kim, Ki Chang Keum, Seong Ha Cheon, Sang Jun Shin, Seung Hyuk Baik, Jae Hee Choen, Sun Young Rha, Jae Kyung Roh, Hei-Cheul Jeung, Hyun Cheol Chung, Joong Bae Ahn,